Chase Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.10 Cr
- Paid Up Capital ₹ 2.07 Cr
- Company Age 32 Year, 10 Months
- Last Filing with ROC 31 Mar 2013
- Open Charges ₹ 1.08 Cr
About Chase Life Sciences
Chase Life Sciences Private Limited (CLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 March 1992 and has a history of 32 years and ten months. Its registered office is in Kolkata, West Bengal, India.
The Corporate was formerly known as Chase Investments Pvt Ltd. The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2013. It's a company limited by shares with an authorized capital of Rs 2.10 Cr and a paid-up capital of Rs 2.07 Cr.
The company currently has active open charges totaling ₹1.08 Cr.
Bulbul Chatterjee, Sunirmoy Mondal, and Samir Chatterjee serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100WB1992PTC054834
-
Company No.
054834
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Mar 1992
-
Date of AGM
30 Sep 2013
-
Date of Balance Sheet
31 Mar 2013
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Chase Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bulbul Chatterjee
|
Director | 25-Feb-2004 | Current |
|
Sunirmoy Mondal
|
Director | 02-Jun-2011 | Current |
|
Samir Chatterjee
|
Director | 01-Feb-2003 | Current |
Financial Performance of Chase Life Sciences.
Enhance accessibility to Chase Life Sciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chase Life Sciences?
Unlock access to Chase Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹1.08 Cr
₹0
Charges Breakdown by Lending Institutions
- Punjab National Bank : 1.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Sep 2002 | Punjab National Bank | ₹1.08 Cr | Open |
How Many Employees Work at Chase Life Sciences?
Unlock and access historical data on people associated with Chase Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chase Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chase Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.